This review examines the therapeutic effects of BPC 157, a stable gastric pentadecapeptide, on fistula healing in rat models. Originally identified as an anti-ulcer agent, BPC 157 remains stable in human gastric juice for over 24 hours and has shown consistent efficacy in promoting the healing of gastrointestinal fistulas. The
